Tradestie Institutional Equity Comparison Engine
PRCS vs GNTA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
GNTA Overall Edge
GNTA Captures Institutional Edge (1โ1 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Genenta Science S.p.A. American Depositary Shares (GNTA) driven by superior Growth & Margin while PRCS counters with relative strength in Momentum & Technical. Fundamentally, PRCS trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus GNTA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, PRCS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GNTA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
PRCS N/M vs GNTA N/M Fwd P/E
Growth & Margin Winner
GNTA
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner
PRCS
1Y +8.1% vs -61.7% ยท 52W Pos 75% vs 18%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
PRCS
NYSE
Parnassus Core Select ETF
Institutional Equity
$28.53
-1.62% 1D
Market Cap
N/A
1M Return
-1.68%
1Y Return
+8.07%
Forward P/E
N/M
Unified AI Score
50.7 / 100
HOLD
Tech 49.0
Fund 51.0
Flow 50.0
Mom 55.3
GNTA
NASDAQ
Genenta Science S.p.A. American Depositary Shares
Biological Products, (No Diagnostic Substances)
$0.98
+20.62% 1D
Market Cap
$39.4M
1M Return
+34.93%
1Y Return
-61.67%
Forward P/E
N/M
Unified AI Score
35.3 / 100
SELL
Tech 15.0
Fund 36.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PRCS +8.07%
GNTA -61.67%
Spread: +64.16 pp (PRCS Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
PRCS TTM Op. Margin: N/A
GNTA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PRCS vs GNTA. Trailing 12-month operating profitability (PRCS N/A vs GNTA 0.0%) and valuation multiples (PRCS N/M vs GNTA N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PRCS | GNTA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $39.4M | Larger Scale | GNTA |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | +0.0% | Higher Growth | GNTA |
| Operating Margin (TTM) Profitability | N/A | 0.0% | Higher Margin | GNTA |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | GNTA |
| Return on Equity (ROE) Capital Efficiency | N/A | -38.0% | Higher ROE | GNTA |
| 52-Week Range Position Momentum | 75% ($24โ$30) | 18% ($1โ$3) | Stronger Trend | PRCS |
| Beta / 30D Volatility Risk Regime | 0.92ฮฒ ยท 22% Vol | 1.45ฮฒ ยท 132% Vol | Lower Realized Risk | PRCS |
| Unified Institutional Score Composite Signal | 50.7 / 100 (HOLD) | 35.3 / 100 (SELL) | Higher Composite | PRCS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PRCS vs GNTA Buy Guide
PRCS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
GNTA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PRCS nor GNTA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.